• Complex
  • Title
  • Author
  • Keyword
  • Abstract
  • Scholars
Search

Author:

Chang Weiping (Chang Weiping.) | Wang Yuan (Wang Yuan.) | Li WenZhi (Li WenZhi.) | Geng Zhimin (Geng Zhimin.)

Indexed by:

Abstract:

Accumulating reports have demonstrated that long non-coding RNAs (lncRNAs) play critical roles in the occurrence and metastasis of cholangiocarcinoma (CCA). LncRNA myocardial infarction associated transcript (MIAT) has been widely reported in hepatocellular carcinoma, pancreatic cancer and colorectal cancer, but the relationship between MIAT and CCA progression has not yet been investigated. In the present study, we found that the expression of MIAT in CCA tissues was prominently higher than that in normal bile duct tissues. Moreover, TCGA-CHOL data in the GEPIA platform further revealed the upregulated expression of MIAT in CCA tissues. Additionally, quantitative real-time PCR results showed that MIAT expression was increased in CCA cell lines compared to the human intrahepatic biliary epithelial cell line. Functionally, MIAT knockdown significantly inhibited cell proliferation and induced G0/G1 phase arrest as well as apoptosis in HuCCT-1 and QBC939 cells. Conversely, ectopic expression of MIAT obviously facilitated the proliferation, cell cycle progression and apoptosis resistance of RBE cells. Mechanistically, MIAT directly interacted with miR-551b-3p and inversely modulated miR-551-3p level in CCA cells. Furthermore, MIAT knockdown reduced the expression of cyclin D1 (CCND1), which was rescued by miR-551b-3p silencing in HuCCT-1 cells. Importantly, CCND1 restoration partially reversed MIAT knockdown-induced proliferation inhibition, G0/G1 phase arrest and apoptosis in HuCCT-1 cells. In conclusion, MIAT was frequently overexpressed in CCA. MIAT contributed to the growth of CCA cells by targeting miR-551b-3p/CCND1 axis.

Keyword:

CCND1 cholangiocarcinoma MIAT miR-551b-3p tumour growth

Author Community:

  • [ 1 ] [Chang Weiping;Geng Zhimin]Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • [ 2 ] [Chang Weiping]Department of General Surgery, The First Affiliated Hospital of Xi'an Medical University, Xi'an, China.
  • [ 3 ] [Wang Yuan]Department of Infectious Diseases, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • [ 4 ] [Li WenZhi]Chang'an District Hospital, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

Reprint Author's Address:

  • [Geng, ZM]Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, 277 Yanta West Rd, Xian 710061, Peoples R China;;

Email:

Show more details

Related Keywords:

Source :

Clinical and experimental pharmacology & physiology

ISSN: 1440-1681

Year: 2020

Issue: 6

Volume: 47

Page: 1067-1075

2 . 0 9 2

JCR@2017

ESI Discipline: PHARMACOLOGY & TOXICOLOGY;

ESI HC Threshold:53

JCR Journal Grade:3

CAS Journal Grade:4

Cited Count:

WoS CC Cited Count: 10

SCOPUS Cited Count: 12

ESI Highly Cited Papers on the List: 0 Unfold All

WanFang Cited Count:

Chinese Cited Count:

30 Days PV: 4

FAQ| About| Online/Total:2020/168761625
Address:XI'AN JIAOTONG UNIVERSITY LIBRARY(No.28, Xianning West Road, Xi'an, Shaanxi Post Code:710049) Contact Us:029-82667865
Copyright:XI'AN JIAOTONG UNIVERSITY LIBRARY Technical Support:Beijing Aegean Software Co., Ltd.